FI109027B - Menetelmä kefeemi-esilääke-esterien valmistamiseksi, menetelmässä käyttökelpoisia yhdisteitä, menetelmä näiden yhdisteiden valmistamiseksi ja niiden käyttö - Google Patents

Menetelmä kefeemi-esilääke-esterien valmistamiseksi, menetelmässä käyttökelpoisia yhdisteitä, menetelmä näiden yhdisteiden valmistamiseksi ja niiden käyttö Download PDF

Info

Publication number
FI109027B
FI109027B FI930604A FI930604A FI109027B FI 109027 B FI109027 B FI 109027B FI 930604 A FI930604 A FI 930604A FI 930604 A FI930604 A FI 930604A FI 109027 B FI109027 B FI 109027B
Authority
FI
Finland
Prior art keywords
formula
compound
acid
ethyl
preparation
Prior art date
Application number
FI930604A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI930604A (fi
FI930604A0 (fi
Inventor
Rudolf Lattrell
Rolf Hoerlein
Theodor Wollmann
Gerd Fischer
Ulrich Stache
Elisabeth Defossa
Uwe Gerlach
Norbert Krass
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI930604A0 publication Critical patent/FI930604A0/fi
Publication of FI930604A publication Critical patent/FI930604A/fi
Application granted granted Critical
Publication of FI109027B publication Critical patent/FI109027B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/587—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI930604A 1992-02-14 1993-02-11 Menetelmä kefeemi-esilääke-esterien valmistamiseksi, menetelmässä käyttökelpoisia yhdisteitä, menetelmä näiden yhdisteiden valmistamiseksi ja niiden käyttö FI109027B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4204349 1992-02-14
DE4204349 1992-02-14

Publications (3)

Publication Number Publication Date
FI930604A0 FI930604A0 (fi) 1993-02-11
FI930604A FI930604A (fi) 1993-08-15
FI109027B true FI109027B (fi) 2002-05-15

Family

ID=6451660

Family Applications (1)

Application Number Title Priority Date Filing Date
FI930604A FI109027B (fi) 1992-02-14 1993-02-11 Menetelmä kefeemi-esilääke-esterien valmistamiseksi, menetelmässä käyttökelpoisia yhdisteitä, menetelmä näiden yhdisteiden valmistamiseksi ja niiden käyttö

Country Status (13)

Country Link
US (2) US5589594A (ja)
EP (1) EP0555769B1 (ja)
JP (1) JP3426629B2 (ja)
KR (1) KR100265191B1 (ja)
AT (1) ATE184609T1 (ja)
CA (1) CA2089441C (ja)
DE (1) DE59309776D1 (ja)
DK (1) DK0555769T3 (ja)
ES (1) ES2137201T3 (ja)
FI (1) FI109027B (ja)
GR (1) GR3032076T3 (ja)
HU (1) HU219587B (ja)
TW (1) TW212181B (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE218572T1 (de) * 1995-12-27 2002-06-15 Hanmi Pharmaceutical Co Ltd Verfahren zur herstellung von cefdinir
US5883247A (en) * 1996-06-10 1999-03-16 Hoffmann-La Roche Inc. Preparation of cephem and isooxacephem derivatives
ITMI20012363A1 (it) * 2001-11-09 2003-05-09 Antibioticos Spa Metodo per la sintesi di catene laterali di cefalosporine
GB0416380D0 (en) * 2004-07-22 2004-08-25 Sandoz Ag Organic compounds
CN100448856C (zh) * 2006-06-26 2009-01-07 山东金城医药化工股份有限公司 一种催化合成ae-活性酯的工艺
ITMI20071628A1 (it) 2007-08-06 2007-11-05 Acs Dobfar Spa Sintesi di 3-alchenilcefalosporine e nuovi intermedi utili ad esse correlati
WO2011029596A1 (en) 2009-09-11 2011-03-17 Lonza Ltd Process for preparing 2-aminothiazol-4-yl-acetic acid derivates
US9409904B2 (en) 2011-08-01 2016-08-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd Compounds and compositions for use in augmentation of glucose
CN102659713B (zh) * 2012-05-07 2014-03-05 山东金城柯瑞化学有限公司 头孢地尼侧链酸活性酯的制备方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK154939C (da) * 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf
JPS5760345B2 (ja) * 1974-12-19 1982-12-18 Takeda Chemical Industries Ltd
US4203899A (en) * 1974-12-19 1980-05-20 Takeda Chemical Industries, Ltd. Thiazolylacetamido compounds
US4668783A (en) * 1974-12-19 1987-05-26 Takeda Chemical Industries, Ltd. Thiazolylacetamido cephalosporin compounds
US4298606A (en) * 1974-12-19 1981-11-03 Takeda Chemical Industries, Ltd. Thiazolylacetamido compounds
DE2760123C2 (de) * 1976-01-23 1986-04-30 Roussel-Uclaf, Paris 7-Aminothiazolyl-syn-oxyiminoacetamidocephalosporansäuren, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
JPS6011713B2 (ja) * 1976-09-08 1985-03-27 武田薬品工業株式会社 セフアロスポリン誘導体およびその製造法
US4120690A (en) * 1976-11-22 1978-10-17 Gulf Oil Corporation 2-Acylaminothiazol-4-ylacetamides as post-emergent selective herbicides
DE2714880A1 (de) * 1977-04-02 1978-10-26 Hoechst Ag Cephemderivate und verfahren zu ihrer herstellung
US4409215A (en) * 1979-11-19 1983-10-11 Fujisawa Pharmaceutical Co., Ltd. 7-Acylamino-3-substituted cephalosporanic acid derivatives and processes for the preparation thereof
FR2476087A1 (fr) * 1980-02-18 1981-08-21 Roussel Uclaf Nouvelles oximes derivees de l'acide 3-alkyloxy ou 3-alkyl-thiomethyl 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
JPS5759894A (en) * 1980-09-30 1982-04-10 Sankyo Co Ltd Cephalosporin for oral administration
US4486425A (en) * 1980-09-30 1984-12-04 Sankyo Company Limited 7-[2-(2-Aminothiazol-4-yl)-2-(syn)-methoxyiminoacetamido]-3-methoxymethyl-3-cephem-4-carboxylates
JPS5896091A (ja) * 1981-12-01 1983-06-07 Sankyo Co Ltd ３−アルコキシメチルセフアロスポリン類の製造法
US4948898A (en) * 1982-06-03 1990-08-14 Hoffmann-La Roche Inc. Process for the manufacture of 1-sulpho-2-oxoazetidine derivatives
JPS604189A (ja) * 1983-06-20 1985-01-10 Sankyo Co Ltd β−ラクタム系化合物の製造法
JPS604190A (ja) * 1983-06-21 1985-01-10 Sankyo Co Ltd セフアロスポリン誘導体の製法
EP0156771A3 (en) * 1984-03-29 1986-03-19 Biochemie Gesellschaft M.B.H. Cephalosporins
US5359057A (en) * 1986-02-07 1994-10-25 Hoffmann-La Roche Inc. Acylation of amines
DE3804841A1 (de) * 1988-02-17 1989-08-31 Hoechst Ag Cephalosporinderivate und verfahren zu ihrer herstellung
DE3809561A1 (de) * 1988-03-22 1989-10-05 Hoechst Ag Ester der 7-(2-(2-aminothiazol-4-yl)-2-(z)- hydroxyiminoacetamido)-3-methoxymethyl-3-cephem-4-carbonsaeure, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen
US4935508A (en) * 1988-08-23 1990-06-19 Bristol-Myers Company Process for cephem prodrug esters
DE3901405A1 (de) * 1989-01-19 1990-07-26 Hoechst Ag Cephalosporinderivate und verfahren zu ihrer herstellung
DE3905119A1 (de) * 1989-02-20 1990-08-23 Bayer Ag Substituierte acrylsaeureester
DE3919259A1 (de) * 1989-06-13 1990-12-20 Hoechst Ag Kristalline cephem-saeureadditionssalze und verfahren zu ihrer herstellung
US5063224A (en) * 1990-07-09 1991-11-05 Eli Lilly And Company R-cefuroxime axetil
WO1992007840A1 (en) * 1990-11-02 1992-05-14 Taisho Pharmaceutical Co., Ltd. Thiazole thioester derivative
YU48484B (sh) * 1991-05-24 1998-09-18 Hoechst Aktiengesellschaft Kristalne kiselinske adicione soli diastereomerno čistih 1-(2,2-dimetilpropioniloksi)-etilestara 3-cefem-4-karbonske kiseline
EP0531875B1 (de) * 1991-09-07 2004-03-24 Aventis Pharma Deutschland GmbH Diastereomer des 3-Cephem-4-carbonsäure-1-(-isopropoxycarbonyloxy)ethylesters und Verfahren zu dessen Herstellung

Also Published As

Publication number Publication date
DK0555769T3 (da) 2000-03-20
ATE184609T1 (de) 1999-10-15
FI930604A (fi) 1993-08-15
JPH069650A (ja) 1994-01-18
CA2089441C (en) 2004-01-20
KR930017908A (ko) 1993-09-20
EP0555769B1 (de) 1999-09-15
JP3426629B2 (ja) 2003-07-14
KR100265191B1 (ko) 2000-09-15
DE59309776D1 (de) 1999-10-21
EP0555769A2 (de) 1993-08-18
US5589594A (en) 1996-12-31
CA2089441A1 (en) 1993-08-15
US5637721A (en) 1997-06-10
ES2137201T3 (es) 1999-12-16
HUT64350A (en) 1993-12-28
HU219587B (hu) 2001-05-28
FI930604A0 (fi) 1993-02-11
GR3032076T3 (en) 2000-03-31
TW212181B (ja) 1993-09-01
HU9300374D0 (en) 1993-04-28
EP0555769A3 (en) 1993-11-24

Similar Documents

Publication Publication Date Title
US6388070B1 (en) Thioester derivatives of thiazolyl acetic acid and their use in the preparation of cephalosporin compounds
EP1572699B1 (en) Crystalline cefdinir salts
JP2004534053A (ja) 結晶性セフジニル酸付加塩及びこれを用いたセフジニルの製造方法
US7405294B2 (en) Intermediate cefdinir salts
FI109027B (fi) Menetelmä kefeemi-esilääke-esterien valmistamiseksi, menetelmässä käyttökelpoisia yhdisteitä, menetelmä näiden yhdisteiden valmistamiseksi ja niiden käyttö
HU184799B (en) Process for producing 7-square bracket-bracket-2-aryl-bracket closed-2-hydroxy-imino-acetamido-sguare bracket closed-ceph-3-eme-4-carboxylic acid derivatives
Lattrell et al. Synthesis and structure-activity relationships in the cefpirome series I. 7-[2-(2-Aminothiazol-4-yl)-2-(Z)-oxyiminoacetamido]-3-[(substituted-1-pyridinio) methyl]-ceph-3-em-4-carboxylates
JPS6157316B2 (ja)
IL118221A (en) Transformed cephalosporins, the process for their preparation and the pharmaceutical preparations containing them
JP4856795B2 (ja) セファロスポリン抗生物質の製造における新規な塩
US9139597B2 (en) Method for the production of ceftobiprole medocaril
HU205121B (en) Process for producing cefalosporing derivatives and pharmaceutical compositions comprising such compounds
KR910000238B1 (ko) 티아졸 유도체의 제조방법
WO1988003924A1 (en) Novel cephalosporin derivatives and their crystalline derivatives
JP4022070B2 (ja) 新規チアゾール化合物およびその製造方法
US20050032771A1 (en) Process for the preparation of cefixime via alkyl-or aryl-sulfonates
KR0174431B1 (ko) 세프디니르의 제조방법
KR900007184B1 (ko) 세팔로스포린 유도체의 제조방법
KR840000254B1 (ko) 옥스-이미노-치환된 세팔로스포린의 헤테로싸이클유도체의 제조방법
SU1130167A3 (ru) Способ получени 3-тиовинилцефалоспоринов или их солей с щелочными металлами или их аддитивных солей с азотсодержащими органическими основани ми
KR830002839B1 (ko) 7α-메톡시세팔로스포린 유도체의 제조방법
JPH0513949B2 (ja)
KR100463920B1 (ko) 신규 세프디토렌 피복실 메지틸렌 설폰산염 및 그 제조방법
WO2005105813A1 (en) Improved process for the manufacture of ceftriaxone sodium
EP0481441A2 (en) Novel cephem compounds, their preparation processes and antibacterial agents

Legal Events

Date Code Title Description
MA Patent expired